cdmo.directory
← Compare landing

AGC Biologics vs Creative Biogene

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAGC BiologicsCreative Biogene
SummaryGlobal CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities.Creative Biogene provides viral vector manufacturing, cell line development, and RNA therapeutic platforms including AAV, lentivirus, adenovirus production, circular RNA synthesis, and lipid nanoparticle formulation for gene therapy and vaccine applications.
Services
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Vaccine Manufacturing
  • CMC Analytical Development
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • mRNA
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
Development capabilities
  • Analytical method development
  • Formulation development
  • Cell line development
  • Analytical method development
  • Formulation development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Prefilled Syringes (PFS)
  • Max bioreactor: Mid-scale clinical (≤2,000 L)
  • Expression: Mammalian
  • Expression: Microbial
  • Expression: Viral Vector
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Stainless Steel
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Microbial
Locations
  • Headquarters, Seattle, Washington, USA
  • Copenhagen, Copenhagen, Denmark
  • Heidelberg, Heidelberg, Germany
  • Milan, Milan, Italy
  • Chiba, Chiba, Japan
  • Yokohama, Yokohama, Japan
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.

Find similar companies

AGC Biologics alternatives · Creative Biogene alternatives

Markdown mirror: /compare/agcbio/creative-biogene.md